Pache is a Board Member and shareholder of Gene Predictis S.A. and Johannes Bitzer is a Scientific Board Member of Gene Predictis S.A. Patient consent for publication Not required ,
, Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited, appropriate credit is given, any changes made indicated, and the use is non-commercial
How the oral contraceptives came to be developed, JAMA, vol.230, pp.421-426, 1974. ,
Health benefits of oral contraceptives, Obstet Gynecol Clin North Am, vol.27, pp.705-726, 2000. ,
Effectiveness of factor V Leiden and prothrombin mutation testing in patients presenting with a first unprovoked venous thromboembolic episode: a systematic review and economic analysis. Ottawa (ON): Canadian Agency for Drugs and Technologies in Health, 2015. ,
Causes of venous thrombosis, Thromb J, vol.14, p.24, 2016. ,
Familial segregation of venous thromboembolism, J Thromb Haemost, vol.2, pp.731-737, 2004. ,
An overview of the development of combined oral contraceptives containing estradiol: focus on estradiol valerate/dienogest, Gynecol Endocrinol, vol.28, pp.400-408, 2012. ,
Hormonal contraceptives and venous thromboembolism: an epidemiological update, Best Pract Res Clin Endocrinol Metab, vol.27, pp.25-34, 2013. ,
Meta-Analysis of 65,734 individuals identifies TSPAN15 and SLC44A2 as two susceptibility loci for venous thromboembolism, Am J Hum Genet, vol.96, pp.532-574, 2015.,
URL : https://hal.archives-ouvertes.fr/hal-01259946
, Genet Med, vol.13, pp.1-16, 2011.
Prothrombin G20210A gene mutation and further prothrombotic risk factors in childhood thrombophilia, Arterioscler Thromb Vasc Biol, vol.19, pp.2568-72, 1999. ,
Development and validation of risk prediction algorithm (QThrombosis) to estimate future risk of venous thromboembolism: prospective cohort study, BMJ, vol.343, p.4656, 2011. ,
Avis d'experts No. 35 Risque thromboembolique sous contraception hormonale, 2015. ,
Risk prediction of developing venous thrombosis in combined oral contraceptive users, PLoS One, vol.12, p.182041, 2017.,
URL : https://hal.archives-ouvertes.fr/hal-01606432
A systematic review of cost-effectiveness analysis of screening interventions for assessing the risk of venous thromboembolism in women considering combined oral contraceptives, J Thromb Thrombolysis, vol.44, pp.494-506, 2017. ,
Economic evaluations of thrombophilia screening prior to prescribing combined oral contraceptives: a systematic and critical review, Appl Health Econ Health Policy, vol.15, pp.583-95, 2017. ,
Health technology assessment and personalized medicine: are economic evaluation guidelines sufficient to support decision making?, Int J Technol Assess Health Care, vol.30, pp.179-87, 2014. ,
Cost-Effectiveness of sacubitril/ valsartan in chronic heart-failure patients with reduced ejection fraction, Swiss Med Wkly, vol.147, p.14533, 2017. ,
Family history unawareness of blood clot risk: links to misdiagnoses and illness uncertainties in personal and expert realms, J Health Commun, vol.20, pp.35-42, 2015. ,
The CoLaus study: a population-based study to investigate the epidemiology and genetic determinants of cardiovascular risk factors and metabolic syndrome, BMC Cardiovasc Disord, vol.8, p.6, 2008. ,
Risk of venous thromboembolism from use of oral contraceptives containing different progestogens and oestrogen doses: Danish cohort study, BMJ, vol.343, p.6423, 2011. ,
Incidence of venous thromboembolism in northern Sweden (veins): a population-based study, Thromb J, vol.12, p.6, 2014. ,
Venous and pulmonary thromboembolism and combined hormonal contraceptives. systematic review and meta-analysis, Eur J Contracept Reprod Health Care, vol.17, pp.7-29, 2012. ,
Trends in the incidence of deep vein thrombosis and pulmonary embolism: a 25-year population-based study, Arch Intern Med, vol.158, pp.585-93, 1998. ,
Venous thromboembolism and subsequent hospitalisation due to acute arterial cardiovascular events: a 20-year cohort study, Lancet, vol.370, pp.1773-1782, 2007. ,
Genetic screening for the predisposition to venous thromboembolism: a cost-utility analysis of clinical practice in the Italian health care system, Value Health, vol.16, pp.909-930, 2013. ,
Risk of recurrence after a first venous thromboembolic event in young women, Haematologica, vol.92, pp.1201-1208, 2007. ,
General population reference values for the French version of the EuroQol EQ-5D health utility instrument, Value Health, vol.13, pp.631-636, 2010. ,
Health-Related quality of life after deep vein thrombosis, Springerplus, vol.5, p.1278, 2016. ,
Catalogue of EQ-5D scores for the United Kingdom, Med Decis Making, vol.31, pp.800-804, 2011. ,
, , 2018.
SwissDRG-Kodes (patientenbezogene Diagnosegruppen) gemäss Verson 5.0, 2014. ,
, FMH Swiss Medical Board. TARMED Tarifbrowser 1.08, valid from 1.1.2012, 2018.
, , 2018.
, , 2018.
Consolidated Health Economic Evaluation Reporting Standards (CHEERS)--explanation and elaboration: a report of the ISPOR Health Economic Evaluation Publication Guidelines Good Reporting Practices Task Force, Value Health, vol.16, pp.231-50, 2013. ,
Genetic testing to identify women at risk of venous thromboembolism with contraceptive pills: Evidence or hope-based tool, Swiss Med Wkly, vol.146, pp.656-63, 2012. ,
Genetics of venous thrombosis: update in 2015, Thromb Haemost, vol.114, pp.910-919, 2015.,
URL : https://hal.archives-ouvertes.fr/hal-01479775
Economic analysis of thrombo inCode, a clinical-genetic function for assessing the risk of venous thromboembolism, Appl Health Econ Health Policy, vol.13, pp.233-275, 2015. ,
Assessing the risk of venous thromboembolic events in women taking progestin-only contraception: a meta-analysis, BMJ, vol.345, p.4944, 2012. ,
Consensus on measurement properties and feasibility of performance tests for the exercise and sport sciences: a Delphi study, Sports Med Open, vol.3, 2017. ,
, , 2018.
Factor X levels, polymorphisms in the promoter region of factor X, and the risk of venous thrombosis, Thromb Haemost, vol.85, pp.1011-1018, 2001. ,